NMRA Neumora Therapeutics, Inc.: institutional ownership and insider trading
132 funds reported holding $174M of Neumora Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $16.4M, with 28 new positions and 27 funds selling out; over the last 12 months insiders bought $15.0M and sold $1.09M on the open market.
Famous investors holding NMRA
- Two Sigma (Two Sigma Investments): $3.82M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $2.15M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $1.82M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $866K, 0.0% of the portfolio
Largest institutional holders of NMRA
- Lunate Holding RSC Ltd — $22.5M
- Siren, L.L.C. — $14.4M
- BlackRock, Inc. (BLK) — $13.2M
- SOFTBANK GROUP CORP. — $10.4M
- TUDOR INVESTMENT CORP ET AL — $8.83M
- VANGUARD GROUP INC — $8.13M
- VANGUARD CAPITAL MANAGEMENT LLC — $7.94M
- MIC Capital Management UK LLP — $7.58M
- FMR LLC — $5.95M
- WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST — $5.63M
Recent NMRA insider trades
- Aug 21, 2026: Aurora Daljit Singh sold 176,060 shares ($269K)
- Aug 19, 2026: Aurora Daljit Singh sold 277,773 shares ($432K)
- Feb 17, 2026: Milligan Michael Lee sold 1,436 shares ($5.13K)
- Feb 17, 2026: Berns Paul L sold 9,819 shares ($34.5K)
5%+ owners
- Kristina Burow: 18.7% (Schedule 13D/A, filed Apr 1, 2026)